Stomach reduction or gastric bypass as risk factor for treatment failure after DAA therapy for hepatitis C?

J Hepatol. 2018 Apr;68(4):851-853. doi: 10.1016/j.jhep.2017.10.035. Epub 2017 Nov 22.

¹ Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
² Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany; German Centre for Infection Research, partner-site Hannover-Braunschweig, Germany.
³ Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany; German Centre for Infection Research, partner-site Hannover-Braunschweig, Germany. Electronic address: [email protected].

No abstract available

Keywords: Direct acting antivirals; Gastric surgery; Hepatitis C; Treatment failure.

Publication types